Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
2GG8
DownloadVisualize
BU of 2gg8 by Molmil
Novel bacterial methionine aminopeptidase inhibitors
Descriptor: COBALT (II) ION, METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE, Methionine aminopeptidase, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-03-23
Release date:2006-06-13
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
Proteins, 66, 2007
2GG5
DownloadVisualize
BU of 2gg5 by Molmil
Novel bacterial methionine aminopeptidase inhibitors
Descriptor: 5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE, COBALT (II) ION, Methionine aminopeptidase, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-03-23
Release date:2006-06-13
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (2.12 Å)
Cite:Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
Proteins, 66, 2007
2GG9
DownloadVisualize
BU of 2gg9 by Molmil
Novel bacterial methionine aminopeptidase inhibitors
Descriptor: COBALT (II) ION, METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE, Methionine aminopeptidase, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-03-23
Release date:2006-06-13
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.05 Å)
Cite:Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
Proteins, 66, 2007
2GG3
DownloadVisualize
BU of 2gg3 by Molmil
Novel bacterial methionine aminopeptidase inhibitors
Descriptor: 4-(4-FLUORO-PHENYLAZO)-5-IMINO-5H-PYRAZOL-3-YLAMINE, COBALT (II) ION, Methionine aminopeptidase, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-03-23
Release date:2006-06-13
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
Proteins, 66, 2007
2GGC
DownloadVisualize
BU of 2ggc by Molmil
Novel bacterial methionine aminopeptidase inhibitors
Descriptor: COBALT (II) ION, METHIONINE, Methionine aminopeptidase, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-03-23
Release date:2006-06-13
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1 Å)
Cite:Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
Proteins, 66, 2007
2I4H
DownloadVisualize
BU of 2i4h by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain co-crystallized with a sulfamic acid inhibitor
Descriptor: CHLORIDE ION, MAGNESIUM ION, N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (2.15 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I3R
DownloadVisualize
BU of 2i3r by Molmil
Engineered catalytic domain of protein tyrosine phosphatase HPTPbeta
Descriptor: CHLORIDE ION, Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-20
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.85 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I3U
DownloadVisualize
BU of 2i3u by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors
Descriptor: Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-20
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.85 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I4E
DownloadVisualize
BU of 2i4e by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors
Descriptor: Receptor-type tyrosine-protein phosphatase beta, VANADATE ION
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.75 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I4G
DownloadVisualize
BU of 2i4g by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with a sulfamic acid (soaking experiment)
Descriptor: CHLORIDE ION, N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE, Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.65 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I5X
DownloadVisualize
BU of 2i5x by Molmil
Engineering the PTPbeta catalytic domain with improved crystallization properties
Descriptor: (4-ETHYLPHENYL)SULFAMIC ACID, CHLORIDE ION, MAGNESIUM ION, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M, Klopfenstein, S.
Deposit date:2006-08-26
Release date:2006-09-05
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.7 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2GHL
DownloadVisualize
BU of 2ghl by Molmil
Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743
Descriptor: 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA, Mitogen-activated protein kinase 14
Authors:Walter, R.L, Mekel, M.J, Evdokimov, A.G, Pokross, M.E, Brugel, T.A.
Deposit date:2006-03-27
Release date:2006-04-11
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (2.099 Å)
Cite:Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.
Bioorg.Med.Chem.Lett., 16, 2006
2GHM
DownloadVisualize
BU of 2ghm by Molmil
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449
Descriptor: 3-(2-CHLOROBENZYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA, Mitogen-activated protein kinase 14
Authors:Walter, R.L, Mekel, M.J, Evdokimov, A.G, Pokross, M.E, Maier, J.A.
Deposit date:2006-03-27
Release date:2006-05-02
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (2.35 Å)
Cite:Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.
Bioorg.Med.Chem.Lett., 16, 2006
2GTN
DownloadVisualize
BU of 2gtn by Molmil
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717
Descriptor: 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE, Mitogen-activated protein kinase 14, SULFATE ION
Authors:Walter, R.L, Mekel, M.J, Evdokimov, A.G, Pokross, M.E, Sabat, M.
Deposit date:2006-04-28
Release date:2006-07-11
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production.
Bioorg.Med.Chem.Lett., 16, 2006
2GTM
DownloadVisualize
BU of 2gtm by Molmil
Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579
Descriptor: 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM, Mitogen-activated protein kinase 14
Authors:Walter, R.L, Mekel, M.J, Evdokimov, A.G, Pokross, M.E, Sabat, M.
Deposit date:2006-04-28
Release date:2006-05-23
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production.
Bioorg.Med.Chem.Lett., 16, 2006
2HK5
DownloadVisualize
BU of 2hk5 by Molmil
Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247
Descriptor: 3-{[2-(1H-BENZIMIDAZOL-1-YL)-6-{[2-(DIETHYLAMINO)ETHYL]AMINO}PYRIMIDIN-4-YL]AMINO}-4-METHYLPHENOL, Tyrosine-protein kinase HCK
Authors:Walter, R.L, Mekel, M.J, Evdokimov, A.G, Pokross, M.E, Sabat, M.P.
Deposit date:2006-07-03
Release date:2006-09-05
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2 Å)
Cite:The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).
Bioorg.Med.Chem.Lett., 16, 2006
<12

 

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon